News
Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of ...
In April 2025, Vir Biotechnology Inc. announced a phase 1b/2 platform study framework to evaluate the safety and efficacy of ...
The following is a summary of “Chronic hepatitis B virus infection increases the risk of kidney disease while antiviral ...
Large-scale data on the hepatitis D virus (HDV)/hepatitis B virus (HBV) co-infection rate is needed to estimate the current ...
Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...
An in-depth look at Hepatitis D, why it’s so severe, and how new therapies bring hope for better treatment and prevention.
Enanta Pharmaceuticals, Inc.’s ENTA share price has surged by 7.51%, which has investors questioning if this is right time to ...
The federal Health Department is proposing universal testing to ensure everyone knows their hepatitis B status, amid concerns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results